Indoco Remedies Ltd.
Fundamentals
- Market cap
- ₹2,138 cr
- ROE
- 0.00%
- Debt / equity
- 0.96
- Div yield
- 0.08%
- 52-week range
- 162.19 — 349.80
The timeline — 3 notes on Indoco Remedies Ltd.
July 2026
- 28 Jul 26 · 4:44 PM IST Brief Brief · Concalls · Small cap
Indoco cuts debt target, USFDA audit still open
Q1 EBITDA margin improved to 10.3% from 3.8%, but management lowered near-term debt repayment goal by ₹30 crore and gave no timeline for USFDA clearance.
- 28 Jul 26 · 12:56 PM IST Brief Brief · Earnings · Small cap
Indoco's ₹97 cr sale masks core loss; auditor flags subsidiary's future
June-quarter profit of ₹65 cr is entirely from the ophthalmic division sale. Excluding it, operations are in the red. Auditor material uncertainty on FPP Holding adds another concern.
- 28 Jul 26 · 12:01 PM IST Brief Brief · Earnings · Small cap
Indoco Q1 profit hinges on ₹97 cr ophthalmic sale gain
Standalone revenue up 6% to ₹408 cr, but pre-tax loss of ₹4.1 cr before exceptional items. EBITDA margin improves to 10.3% but core business under pressure.